No single test can currently be used to definitively diagnose prostate cancer, and researchers are now exploring whether multianalyte panels may be useful in helping clinicians detect this highly prevalent disease.
In an upcoming Webinar offered by the American Association for Clinical Chemistry (AACC), Washington, DC, a world-renowned prostate cancer expert will describe results from the latest and most pertinent studies related to improving the process of prostate cancer detection.
The Webinar will be presented on March 12, from 2 pm to 3 pm, EST.
Attendees will learn:
William Catalona, MD, is a researcher and prostate cancer surgeon, and is well-known for having been the first to show that prostate-specific antigen (PSA) is the most accurate method for detecting prostate cancer. Catalona also helped develop the "free" PSA test as a means of improving the accuracy of prostate cancer screening. He leads a multiinstitutional research group that has collected DNA samples and clinical data on hundreds of brothers with prostate cancer in an effort to identify prostate cancer genes that could lead to new tests for this highly prevalent disease.
AACC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
AACC also designates this program for a maximum of 1.0 ACCENT credit hours towards the AACC Clinical Chemist's Recognition Award. AACC is an approved provider of continuing education for clinical laboratory scientists in the states of California, Florida, Louisiana, Montana, Nevada, North Dakota, Rhode Island, and West Virginia. (ACCENT-approved programs are also accepted by ASCLS for continuing education credit.)
Click here for more information and to register.